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Rational Design of Alkylene-Linked
Bis-Pyridiniumaldoximes as Improved
Acetylcholinesterase Reactivators
approach yielded 2-pralidoxime (2-PAM) and its ana-
logs, which are effective antidotes for some organo-
phosphates but not for others, such as soman [3, 4].
The variable performance is reportedly due to different
rates of the irreversible dealkylation (aging) of various
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tional reason for such variable performance is that the2Mayo Clinic Cancer Center
3Tumor Biology Program effect of an oxime depends on the equilibrium constant
of Scheme I for a given organophosphate (Figure 2).4Molecular Neuroscience Program
5Molecular Biophysics Program Prior to aging, oximes are effective only when enzyme
dephosphorylation is faster than oxime dephosphoryla-Mayo Foundation for Medical Education and
Research tion. To improve 2-PAM, a clinical mainstay for treating
organophosphate poisoning and yet a known alkylating200 First Street SW
Rochester, Minnesota 55905 agent, we made a series of dimeric oximes in pursuit of
the following objectives: (1) increasing the affinity for
the phosphorylated hAChE; (2) accelerating the rate of
enzyme dephosphorylation; (3) reducing therapeuticSummary
dosage and therefore minimizing the nonspecific toxic-
ity; and (4) gaining ability to counteract a wider rangeTo improve the potency of 2-pralidoxime (2-PAM) for
treating organophosphate poisoning, we dimerized of organophosphates. These analogs were designed in
light of the pioneering work of Wilson and Ginsburg and2-PAM and its analogs according to Wilson’s pioneering
work and the 3D structure of human acetylcholinester- the 3D structure of diisopropylphosphoryl-hAChE, an
immediate product of the reaction between isofluro-ase (hAChE) inactivated by isoflurophate. 1,7-Hepty-
lene-bis-N,N’-syn-2-pyridiniumaldoxime, the most po- phate and hAChE. The results described here help to
explain why dimeric reactivators are more potent in re-tent of the alkylene-linked dimeric reactivators, was
readily synthesized using bistriflate and is 100 times activating hAChE than monomeric ones, and they pro-
vide insights into the design of further improved hAChEmore potent than 2-PAM in reactivating hAChE poisoned
by isoflurophate. Experimental and computational stud- reactivators.
ies confirm that 2-PAM in its biologically active form
adopts the syn-I configuration. Further, they suggest
Resultsthat the improved performance of dimeric oximes is
conferred by two-site binding with one oxime pointing
Designtoward the diisopropyl ester at the catalytic site of
Inspired by the work of Wilson and Ginsburg [3, 9–14],hAChE and the other anchored at the peripheral site. This
we set out to synthesize dimeric analogs of 2-PAM thattype of binding may induce a conformational change in
had not been reported in the literature. It was first neces-the acyl pocket loop which modulates the catalytic site
sary to decide whether the dimeric analogs adopt thevia a domino effect.
syn-I, syn-II, or anti configuration (see Figure 1 for syn
and anti definitions for oximes as well as the new nomen-Introduction
clature for oximes). Initially, anti-2-PAM was thought to
be the biologically active and most stable configuration,Organophosphorous compounds have been used as
into which syn stereoisomers convert slowly at roomchemical weapons (e.g., nerve agents such as sarin, so-
temperature (Figure 1) [15, 16]. Later, syn-I-2-PAM wasman, and VX) and as insecticides (e.g., chlorpyrifos,
suggested to be the biologically active and most stableparathion, and coumaphos) [1]. Exposure to even small
configuration [17]. Recently, syn-II-2-PAM has been pro-amounts of an organophosphorus compound can be
posed to be the biologically active configuration [18].fatal. The mechanism of organophosphate poisoning
This conflict in the literature prompted us to performinvolves phosphorylation of a serine hydroxyl group in
density functional theory calculations. Using the B3LYP/the active site of human acetylcholinesterase (hAChE),
6-31G(d,p)//B3LYP/6-31G(d,p) method and the On-leading to inactivation of this essential enzyme. The ther-
sager solvent model [19–22], we found that syn-I-2-PAMapeutic approach to organophosphate poisoning is to
is 4 kcal/mol more stable than anti-2-PAM in vacuoreactivate hAChE with a site-directed nucleophile. After
or in water (Figure 1), and that syn-I-2-PAM is 0.6 andreversibly binding to the active site, the nucleophile re-
1.0 kcal/mol more stable than syn-II-2-PAM in vacuoacts with the phosphorylated hydroxyl group to release
and in water, respectively (Figure 1). These results fit thefree, active enzyme while becoming phosphorylated it-
experimental observation that crystalline 2-PAM adoptsself in turn [2]. Drug design based on this chemical
the syn-I configuration and are consistent with the re-
ported proposal of syn-I-2-PAM being the biologically*Correspondence: pang@mayo.edu
active and most stable configuration [17, 23]. It is there-6Current address: University of Washington, Department of Struc-
tural Biology, Box 357742, Seattle, Washington 98195. fore plausible that the biologically active form is syn-I
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hAChE, pyridinium aldoximes are structurally analogous
to 9-amino-1,2,3,4-tetrahydroacridine (THA), which binds,
according to our previous work [24], to the catalytic and
peripheral sites of hAChE (Figure 2). The expectation
that these oximes bind to the same THA binding sites
was confirmed by docking studies of 2-PAM and its
analogs. We therefore hypothesized that the affinity for
hAChE and the reactivation potency could be improved
by tethering two oxime molecules with an alkyl chain
spaced for simultaneous binding at the two THA binding
sites. Two considerations support this hypothesis. First,
the effective concentration of bis-oxime rises when one
moiety anchors at the peripheral site and facilitates bind-
ing of the other moiety at the catalytic site because of
the proximity effect (Figure 2). Elevating the effective
concentration of dephosphorylated oxime shifts the
chemical equilibrium toward the active enzyme, ac-
cording to the principle of mass action (Scheme I of
Figure 2). Second, the bis-oxime acquires a bulky phos-
phate group during enzyme reactivation and subse-
quently becomes too large to bind simultaneously at
both catalytic and peripheral sites. The resulting fall in
local concentration of phosphorylated oxime shifts the
equilibrium further toward active hAChE. This hypothe-
sis led to the synthesis of analogs 1e–h, 2e–h, and 3e–h
linked with alkyl chains (  6, 7, 8, and 9) intended to
bridge putative binding sites approximately 18 A˚ apart
on hAChE, as reported previously (Figure 2) [24]. Short-
chain analogs 1a–d (  2, 3, 4 and 5) and 3b–d ( 
3, 4 and 5) were also made and tested to ensure identifi-
cation of the optimal length of linker. Analogs 1a–e ( 
2, 3, 4, 5 and 6), 1g (  8), 2b (  3), 2e (  6), and
3b–e (  3, 4, 5, and 6) were known in the literature
[3, 9–14]. However, these compounds were synthesized
in this study for biological testing and for improving
synthetic yields, which were reportedly less than 7% for
3b–e.
It might seem that introducing a superior ligand moiety
such as THA [24] could more effectively increase the
affinity of an aldoxime for hAChE. However, in the re-
sulting structures, the high affinity moiety would com-
pete for binding to the catalytic site, reduce oxime’s
access to the phosphonyl group of the enzyme, and
impede reactivation. Introducing a high affinity periph-
eral-site ligand (e.g., propidium [25]) would cause differ-
ent problems: strong binding and persistent inhibition
regardless of phosphorylation. For these reasons, we
confined our investigation to homodimeric reactivators.
Synthesis
Compounds 1b–h and 2e–h were readily synthesized in
good yields by quaternization of 3- or 4-pyridinealdox-
ime with dibromoalkanes using the method by Poziomek
et al. [9]. Compound 1a was prepared in a higher yieldFigure 1. The 3D Structures and Free Energies of 2-PAM in Three
Energetically Stable Conformations Optimized by the DFT Calcula- by our modified procedure using a Parr reaction vessel.
tions However, the dibromoalkane protocol was problematic
Face view is shown on the left, side view is shown on the right, and for compound 3. Low yields ( 7%) were obtained, prob-
E is the sum of electronic and thermal free energies. ably due to steric hindrance of pyridine nitrogen by the
2-syn-pyridinealdoxime [3, 15]. We unsuccessfully at-
tempted to couple two 2-pyridinealdehydes with dibro-and that syn-I-2-PAM should accordingly be used in the
design of improved 2-PAM derivatives. moalkane and then convert the aldehydes to oximes
in DMSO or aqueous media. Subsequently, by usingViewed as pharmacophores to the active site of
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Figure 2. The Reactivation Mechanism and the Design and Synthesis of Dimeric Oximes
bistriflates [26, 27] as alkylating reagents in CH3CN at length (Figure 3). To make certain of discovering optimal
compounds, a wide range of lengths was tested in seriesroom temperature, we succeeded in coupling two syn-
1 and 3. Shorter chain analogs of 2 were not produced,2-pyridinealdoximes. The resulting triflate salts were
since 2e–h were only slightly better than 2-PAM, andsubjected to ion-exchange chromatography on Dowex-
3-methylpyridiniumaldoxime was less effective thanCl resins, yielding 3b–h in high yields (72%–85%) on
2-PAM or 4-methylpyridiniumaldoxime (4-PAM) [16]. Ingram scale (Scheme II of Figure 2). This method repre-
the screening assay, the most effective of the 4-pyridini-sents greater than a 10-fold improvement in yield com-
umaldoxime reactivators were the shortest, 1a and 1b,pared to previously reported methods [3, 15]. However,
yielding50% reactivation when tested at a concentra-quaternization of syn-2-pyridinealdoximes with ethyl-
tion of 1 M. Under the same conditions, however, 3eene-bistriflate failed to yield 3a.
with a hexylene chain and 3f with a heptylene chain
demonstrated 89  3.7% and 99  3.9% reactivations,
respectively (n  7). Although the difference in reactiva-
Testing tion potency between 3e and 3f was not significant by
For in vitro reactivation screening, hAChE from red blood simple t test, reactivation by 3f in each experiment aver-
cells was inhibited by the organophosphate drug, aged 10% greater than that by 3e (p  0.01). Analogs
echothiophate, followed by treatment with 1.0 M re- with longer and shorter linkers were substantially less
activator for 60 min (see Experimental Procedures). Un- effective. Thus, the most effective reactivator in our se-
der these conditions, 2-PAM led to modest reactivation ries was a heptylene-linked bis-oxime.
(6%), and 2e–h were only slightly more effective (7%– Further experiments were performed to determine the
19%). By contrast, 1e–h and 3e–h were markedly more kinetics of reactivation, since enzyme activity measured
effective (reactivation up to 52% and 99%, respectively). at one time and concentration does not define inherent
potential. Kinetic constants for reactivation by 2-PAM,Reactivation was expected to depend on linker chain
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by 3 orders of magnitude, to a value of 0.0026 min1 for
1h. Values from series 3 followed an inverted U-curve:
k3 first increased to a peak at 0.12 min1 with 3c, then
declined to a minimum of 0.023 min1 with 3h.
Affinity for hAChE was measured in two ways. First,
an estimate of oxime affinity for the free enzyme was
obtained by determining Ki values for hAChE inhibition
in standard experiments on substrate kinetics (Table 1).
By this measure, compounds 3b–g were generally about
3-fold more potent inhibitors than their counterparts,
1b–g. In both series, Ki decreased by roughly 2-fold with
each methylene addition. However, a 10-fold decrease
was seen at the change from 5 to 6 methylene groups
in 3d to 3e.
In order to determine oxime affinity for phosphory-
lated enzyme, KD values were extracted from the data
on reactivation as a function of time and oxime concen-
tration (see Biological Testing under Experimental Pro-
cedures). For most compounds, KD was less than or
equal to Ki, and, like Ki, it decreased with increasing
linker length. This effect was more pronounced with
series 1 (300-fold change from 1b to 1h) than with series
3 (35-fold change from 3b to 3h). In series 3, moving
from 3d to 3e, KD did not show the large drop that was
seen in Ki, but it did drop markedly in series 1, moving
from 1f to 1g.
The overall efficiency for reactivation of hAChE is de-
scribed by the ratio k3/KD. By this definition, the most
effective reactivator optimally combines rapid action
and high affinity for the phosphorylated hAChE. Because
k3/KD in the bisoximes is maximal for 3f, this agent was
compared further with 2-PAM in order to determine rela-
tive potency in reactivating hAChE after inhibition with
echothiophate and also isoflurophate. Although isofluro-
phate-treated hAChE did not reactivate as readily as
echothiophate-treated hAChE, full dose-response curves
demonstrated that 3f was 100 times more effective than
2-PAM in reactivating hAChE poisoned by either organo-
phosphate (Figure 3).
Modeling of Diisopropylphosphoryl-hAChE
It is difficult to experimentally determine the 3D structure
of diisopropylphosphoryl-hAChE because dealkylationFigure 3. Reactivation of the Poisoned hAChE by Oximes and Their
of the diisopropylphosphoryl group (referred to asDimeric Analogs
“aging” of the phosphorylated hAChE) occurs soThe top shows reactivation activities of the echothiophate-poisoned
quickly. However, this structure is accessible computa-AChE by 2- and 4-PAM and their dimeric analogs linked with different
numbers of methylene groups. All agents were tested at a concen- tionally through a systematic conformational search of
tration of 106 M and an exposure time of 60 min. The bottom shows the diisopropylphosphoryl group attached to Ser200 fol-
dose-response curves demonstrated by 3f or 2-PAM in reactivating lowed by energy minimization and multiple molecular
AChE poisoned by echothiophate (Echo) or isoflurophate (ISO).
dynamics (MD) simulations [28–31]. In the modeling of
the phosphorylated hAChE, the common “loop-in” for-
mation (the side chain of Arg289 pointing outward, Fig-4-PAM, and bis-oximes were derived from the time
course of hAChE recovery in the presence of varying ure 4) of the acyl pocket loop (residues 278–292, based
on the Torpedo numbering) was used in the hope thatconcentrations of oxime (see Experimental Procedures).
With echothiophate-treated hAChE, reactivation rates the diisopropylphosphoryl group may induce the “loop-
out” conformation (the side chain of Arg289 pointingdepended on oxime structure and concentration (Figure
3) and were well described by theoretical curves based inward, Figure 4) of the acyl pocket loop found uniquely
in the crystal structure of an aged phosphylated AChEon the presumed reaction scheme.
The reactivation rate constants (k3) for all oximes stud- (PDB ID code 2DFP) [32], if indeed the loop-out confor-
mation is energetically more stable than the loop-in con-ied (Table 1) showed that 1b was the fastest reactivator,
with a k3 of 1.2 min1. As the alkylene linkage in this formation. Despite the enhanced sampling achieved by
performing 20 independent 1.0 ns (1.0 fs time step) MDseries lengthened, the rate constant steadily decreased
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Table 1. Kinetic Constants for Oxime Reactivators
Compound n* Ki (M) KD (M) k3 (min1) k3/KD*1000
4-PAM 0 580 733 0.055 0.1
1a 2 270 62 0.700 11
1b 3 170 66 1.200 18
1c 4 57 75 0.740 10
1d 5 35 20 0.440 23
1e 6 11 10 0.185 18
1f 7 3.3 4.3 0.056 13
1g 8 2.1 0.3 0.005 20
1h 9 1.3 0.2 0.002 12
2-PAM 0 470 250 0.330 1.3
3b 3 65 21 0.048 2.3
3c 4 32 15 0.120 7.6
3d 5 21 6.9 0.091 13
3e 6 2.2 2.4 0.120 51
3f 7 1.3 1.4 0.120 85
3g 8 0.6 0.5 0.034 66
3h 9 0.3 0.6 0.023 37
*  number of methylene groups used to tether two pyridiniumaldoximes.
simulations of the phosphorylated hAChE with different structures of dealkylated (aged) phosphorylated AChE
(PDB ID codes 1CFJ, 1SOM, 1VXO, and 2DFP), or form-initial velocities [28–31], no conversion to the loop-out
conformation was observed in any of these simulations. ing two hydrogen bonds with Glu199 and a water mole-
cule, as seen in the crystal structure of phosphorylatedIt would be interesting to compare the average potential
energy of the “apo” phosphorylated hAChE adopting AChE (PDB ID code 1VXR) [32, 33]. However, the unique
hydrogen bond pattern of His440 in the diisopropylphos-the loop-in conformation in water with that of the loop-
out conformation. However, due to the limitation of our phoryl-hAChE structure predicted by computer model-
ing is akin to the report that His440 is mobile in thecomputing resources, we did the comparative energet-
ics studies using the hAChE complexes instead of the active site of hAChE [33].
apo enzyme (vide infra). In the most energetically stable
diisopropylphosphoryl-hAChE structure with the loop- Modeling of Diisopropylphosphoryl-hAChE-3f
The EUDOC-generated diisopropylphosphoryl-hAChE-in conformation refined by multiple MD simulations, the
double-bond oxygen atom of the phosphate group rests 3f structure with the loop-in conformation was refined
by ten independent 1.0 ns (1.0 fs time step) MD simula-in the oxyanion hole of the active site of hAChE. That
result is consistent with the assignment of this oxygen tions with different initial velocities. No conversion to
the loop-out conformation was observed in any of theseatom to the oxyanion hole in five crystal structures of
phosphorylated AChE (PDB ID codes 1CFJ, 1SOM, simulations, despite the fact that the active site of hAChE
was occupied, in this case, by two bulky groups of the1VXO, 1VXR, and 2DFP) [32, 33]. The two isopropyl
groups interact favorably with Trp84, Gly119, Tyr121, diisopropylphosphoryl ester and 3f. A new set of ten
simulations was then carried out with the same diisopro-Trp233, Phe288, Phe290, Tyr330, and Phe331. Interest-
ingly, His440 forms two hydrogen bonds with Glu199 pylphosphoryl-hAChE-3f structure, except that the
loop-in conformation was manually changed to the loop-and Glu327, instead of forming two hydrogen bonds
with Glu327 and the phosphate, as seen in the crystal out conformation according to the crystal structure of
Figure 4. The Effects of the Binding of 1b and 3f on the Backbone Conformation of the Acyl Pocket Loop in Diisopropylphosphoryl-hAChE
Apo, diisopropylphosphoryl-hAChE; 3f, diisopropylphosphoryl-hAChE bound with 3f; 1b, diisopropylphosphoryl-hAChE bound with 1b; and
overlay, an overlay of the three conformations showing that the loop is pushed out further when the diisopropyl ester is lifted in the 1b
complex.
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Figure 5. Close-Up Views of the Binding of
1b and 3f in Diisopropylphosphoryl-hAChE
The top shows binding with 3f, the middle
shows binding with 1b, and the bottom shows
an overlay of the two complexes demonstra-
ting that the diisopropyl ester is lifted in the
1b complex.
an aged phosphylated hAChE (PDB ID code 2DFP) [32]. Asp72; the oxime oxygen atom forms a hydrogen bond
with a water molecule; the pyridinium group at the cata-In the second set of simulations, no conversion to the
loop-in conformation was observed either. However, the lytic site interacts with Trp84, Tyr330, and Tyr334 via
cation-pi interactions and electrostatically with Asp72average potential energy of the most energetically stable
protein complex structure adopting the loop-out confor- and Glu199; the oxime oxygen atom at the catalytic site
forms a hydrogen bond with a structural water moleculemation in water simulation is 22.1 kcal/mol lower than
the corresponding one adopting the loop-in conforma- that is a part of the hydrogen bond network consisting
of Tyr130, Glu199, Tyr330, and five structural water mol-tion. This energy difference suggests that the loop-out
conformation is preferred for the acyl pocket loop in ecules at the catalytic site; one isopropyl group has van
der Waals interactions with the alkylene chain of 3f; andthe diisopropylphosphoryl-hAChE-3f complex and that
more simulations with longer time frames are required the distance of the oxime oxygen atom to the phospho-
rus atom is 7.2 A˚, while the distance between the twoto observe the exchange of the two loop conformations.
In the most energetically stable Michaelis-Menten com- oxime-oxygen atoms is 13.0 A˚.
plex of diisopropylphosphoryl-hAChE-3f with the loop-
out conformation (Figure 5), the pyridinium group at the Modeling of Diisopropylphosphoryl-hAChE-1b
The average potential energy of the most energeticallyperipheral site interacts with Tyr70, Tyr121, and Trp279
via cation-pi interactions and electrostatically with stable 1b complex structure adopting the loop-out con-
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formation in water is 1.0 kcal/mol lower than the corre- the biologically active configuration [17] should be used
in the design of further improved 2-PAM analogs assponding one adopting the loop-in conformation. This
small energy difference was confirmed by 20 additional hAChE reactivators.
independent 2.0 ns (1.0 fs time step) MD simulations
with different initial velocities (ten for the loop-in and
Structure-Activity Relationshipten for the loop-out). Likewise, in the most energetically
Both series 1 (para-oxime) and series 3 (ortho-oxime)stable Michaelis-Menten complex of diisopropylphos-
demonstrated the dependency of reactivation potencyphoryl-hAChE-1b with the loop-out conformation (Fig-
upon linker chain length (Figure 3). However, the fastesture 5), one pyridinium group interacts with Tyr70, Tyr72,
and more effective reactivator for the para series is theTyr334, and Asp72; the other pyridinium group interacts
dimer linked with three methylene groups (1b), whereaswith Trp84, Glu199, and Asp72; one hydroxyl hydrogen
the most effective one for the ortho series is linkedatom forms an aromatic hydrogen bond with the aro-
with seven methylene groups (3f). The 3D structures ofmatic ring of Trp279 [34]; the other oxime group has
complexes 1b and 3f can explain the different require-a hydrogen bond with Glu199 and points toward the
ments of linker chain length for reactivation improved byphosphoric acid diisopropyl ester; one isopropyl group
two-site binding. In the 3D structures, 1b and 3f spanhas van der Waals interactions with the alkylene chain
the active site of the phosphorylated hAChE; and theof 1b; and the distance between the phosphorus atom
distances between the two oxime-oxygen atoms as nu-and the oxime oxygen atom is 6.5 A˚, while the distance
cleophiles in 1b and in 3f are 14.7 A˚ and 13.0 A˚, respec-between the two oxime-oxygen atoms is 14.7 A˚. Interest-
tively, even though 1b is tethered by a short chain. It isingly, because of the hydrogen bond of the oxime group
therefore conceivable that short linkers are required forwith Glu199, the pyridinium group goes underneath the
the more effective para-bisoximes and that long linkersdiisopropyl ester by lifting the ester and, in turn, pushes
are required for the more effective ortho-bisoximes.the acyl pocket loop further out relative to the acyl
As early as the 1950s, some compounds 1 (  1, 2,pocket loop of diisopropylphosphoryl-hAChE-3f (Figure
3, 4, 5, 6, 8, and 10), 2 (  3 and 6), and 3 (  3, 4,4). Another difference compared to the complex with 3f
5, and 6) had been made and reported collectively byis that the hydrogen bond network at the catalytic site
a number of independent groups [3, 9–14]. However,in the 1b complex is comprised of Tyr130, Glu199,
the explanation of why the dimeric analogs are moreTyr330, and three structural water molecules.
potent in reactivating hAChE than the monomeric ones
was not satisfactory, nor was it fully understood why
2-PAM is more potent than 4-PAM, especially since theDiscussion
assumption that 2-PAM adopts the anti configuration
[16] must be abandoned. In the present study, we haveBiologically Active Configuration of 2-PAM
While in vivo studies are underway to evaluate 3f as a found that the calculated interaction energy of a reacti-
vator tends to be inversely related to the reactivationpotential antidote for organophosphate poisoning, the
present work helps to understand why dimeric oximes potency (Table 2). The finding supports the design prin-
ciple described above: reactivators with increased affin-are more potent than the monomeric oximes and pro-
vides insights into rational design of further improved ity for the active site of the phosphorylated hAChE accel-
erate the rate of enzyme dephosphorylation (Scheme I ofhAChE reactivators. A key insight relates to oxime con-
formation. Contradictory to the early reports [15–17], Figure 2). It is evident from the decomposed interaction
energies in Table 2 that the binding of oxime derivativessyn-II-2-PAM (E-syn-2-PAM, Figure 1) has recently been
proposed to be the biologically active form [18]. This to the inactivated hAChE is driven mainly by the electro-
static interactions between the cationic oximes and theproposal was based on the finding that the reactivation
activity of a 2-PAM analog constrained in the E-syn electron-rich binding region of the enzyme. This ex-
plains, at the atomic resolution, the experimental obser-conformation was comparable to that of 2-PAM itself
[18]. Without knowing the relative energies of 2-PAM in vation that the neutral 2-pyridinealdoxime is far less
efficient than the cationic 2-PAM in reactivating hAChEits different conformations and their interaction energies
with the inactivated hAChE, it is difficult to determine [16]. The data in Table 2 also indicate that 2-PAM is
more potent in reactivating hAChE than 4-PAM, becausewhether 2-PAM adopts the syn-I or syn-II conformation
in its biologically active form. According to our density 2-PAM better fits the active site of the poisoned hAChE
than 4-PAM both sterically and electrostatically. An ad-functional theory calculations, syn-I-2-PAM is 0.6 and
1.0 kcal/mol more stable than syn-II-2-PAM in vacuo ditional reason is that the phosphorylated 4-PAM that
is generated after enzyme reactivation has a half-lifeand in water, respectively (Figure 1). These results imply
that the interaction energy of syn-II-2-PAM with the inac- (980 s) 100 times longer than that of the phosphorylated
2-PAM (10 s), and the subsequent inhibition of hAChEtivated hAChE ought to be 0.6 kcal/mol lower than that
of syn-I-2-PAM for 2-PAM to adopt the syn-II conforma- by the phosphorylated 4-PAM makes 4-PAM less effec-
tive in reactivating the phosphorylated hAChE thantion in the active site of diisopropylphosphoryl-hAChE.
On the contrary, the docking studies reveal that the 2-PAM [37]. Furthermore, the nearly doubled interaction
energies of the dimeric oximes relative to those of thecalculated interaction energy of syn-II-2-PAM is 0.8 kcal/
mol higher than that of syn-I-2-PAM (Table 2). In addi- monomeric ones in Table 2 indicate that the two-site
binding of the dimeric oximes markedly lowers the inter-tion, the 2-pyridiniumaldoxime group of 3f in the most
energetically stable complex of diisopropylphosphoryl- action energies (increases the binding affinities). These
structural insights explain why dimeric reactivators arehAChE-3f also adopts the syn-I configuration. Alto-
gether, the syn-I configuration previously reported as more potent than the monomeric ones.
Chemistry & Biology
498
Table 2. Interaction Energies of Oximes with Diisopropylphosphoryl-hAChE
Eint (kcal/mol) Eout-Ein
Reactivator vdw ele total k3/KD*1000 (kcal/mol)
3f 49.7 307.1 356.8 85 22.1
1b 41.4 312.5 353.9 18 1.0
syn-I-2-PAM 25.9 140.2 166.1 1.3 256.6
syn-II-2-PAM 21.8 143.5 165.3 N/A 248.4
syn-I-4-PAM 22.7 123.9 146.6 0.1 233.2
Calculated energies with enzyme adopting the loop-out conformation (Eout) are shown along with experimentally determined kinetic constants
of diisopropylphosphoryl-hAChE complexed with oximes (k3/KD). Differences in the average potential energy of the hAChE complex between
the loop-out and loop-in conformations of the acyl pocket loop are also given (Eout-Ein).
Domino Effect ing those with interaction energies lower than that of
bis-7-syn-I-2-PAM, and testing them experimentally. InOne would need an investigation of the conformational
stability of the “apo” phosphorylated hAChE adopting our opinion, further development of hAChE reactivators
should be directed toward finding novel nucleophilesthe loop-out conformation to determine whether the
unaged hAChE poisoned by isoflurophate adopts the that are capable of dephosphorylating the dealkylated
phosphoryl hAChE, i.e., aged hAChE. The search canloop-out conformation like the aged phosphylated Tor-
pedo AChE [32]. However, our modeling of loop-in and be facilitated by the concepts illustrated here, dimeriza-
tion of low-affinity nucleophiles and theoretical estima-loop-out conformations in the hAChE complexes does
suggest that the loop-out conformation is preferred tion of interaction energies, before launching into syn-
thesis and testing.in diisopropylphosphoryl-hAChE. This preference is
strengthened when diisopropylphosphoryl-hAChE is
complexed with monomeric oximes, because much Significance
larger differences in average potential energy of the
hAChE complex (233.2 to 256.6 kcal/mol) were found Employing the bivalence approach, we have devel-
between the two loop conformations (Table 2). Although oped 1,7-heptylene-bis-N,N’-syn-2-pyridiniumaldox-
the acyl pocket loop is relatively distal to the bound ime dichloride. This hAChE reactivator can be readily
reactivators, overlay of the two computer-generated 1b synthesized by using bistriflate and is a promising anti-
and 3f complexes reveals significant conformational dote with less liability to induce chronic toxicity caused
changes of the acyl pocket loop and of the diisopro- by alkylation or other nonspecific means, as it is 100
pylphosphoryl ester (Figure 5). These changes are ap- times more potent than 2-PAM in reactivating hAChE
parently caused by the binding of different reactivators after exposure to echothiophate or isoflurophate. Our
via a domino effect involving the acyl pocket loop, the study suggests the use of syn-I-2-PAM in rational de-
diisopropylphosphoryl ester, and the bound reactivator. sign of 2-PAM analogs as improved hAChE reactiva-
This domino effect is important to rational design of tors. Our results also indicate that novel hAChE reacti-
hAChE reactivators in that it calls for the attention to vators can be developed by dimerizing appropriate
the modulation of the active site by the relatively distal, nucleophiles while taking into account the modulation
species-specific actyl pocket loop. On the one hand, of the active site by the relatively distal actyl pocket
our computationally exhaustive multiple MD simulation loop via the domino effect involving the acyl pocket
studies with an equivalent of 250,000 hr of CPU time of loop, the alkylphosphoryl ester, and the bound reacti-
the 2.2 Ghz Xeon P4 processor failed to generate the vator. This kind of approach may ultimately result in
loop-out conformation a priori, which underscores the reactivators capable of dephosphorylating the aged
crucial role of the insightful X-ray structure adopting hAChE.
the loop-out conformation in rational design of hAChE
reactivors. On the other hand, the recently reported
Experimental Procedures
AChE species specificity demonstrated by reversible
and pseudo-irreversible AChE inhibitors [38, 39] would Syn-pyridine-2-aldoxime, pyridine-3-aldoxime, pyridine-4-aldox-
ime, 1,3-dibromopropane, 1,4-dibromobutane, 1,6-dibromohexane,discourage the direct use of the X-ray structures of Tor-
1,7-dibromoheptane, 1,8-dibromooctane, and 1,9-dibromononanepedo AChE in the design of hAChE reactivators, espe-
were purchased from Aldrich Chemical Company (Milwaukee, WI)cially given the fact that the amino acid sequence of the
and were used without further purification. 1,2-dibromoethane andacyl pocket loop is not conserved between human and
1,5-dibromopentane were purchased from Acros Organics USA
Torpedo enzymes. A combination of the experimental (Morris Plains, NJ) and were used without further purification. Methyl
and computational approaches is suggested here to t-butylether (MTBE), methylene chloride, ethyl acetate, and acetoni-
trile were purchased from Fisher Scientific Company, L.L.C. (Pitts-address the domino effect on each designed hAChE
burgh, PA) and used as received, except for methylene chloride thatreactivator.
was distilled from calcium hydride before use. Pyridine-2-aldoxime
methochloride was purchased from Sigma (St. Louis, MO). Bis-Reactivators of the Aged hAChE
triflates were prepared in accordance with a published procedure
Following on the present work, still better hAChE reacti- [26]. All reactions were performed under N2 with stirring. Elemental
vators might be crafted by docking various oxime deriv- analyses were performed by either Quantitative Technologies Incor-
porated or Atlantic Microlabs Incorporated on recrystallized sam-atives in consideration of the domino effect, synthesiz-
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ples after lypholization from 0.5 ml of water. The recrystallization 1,9-Nonylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1h)
Yield: 74% as white needles; 1H-NMR (300 MHz, DMSO-d6)  12.83using water was carried out to remove residual methanol resulted
from the previous crystallization using methanol/ether. NMR spectra (s, 2 H), 9.03 (d, 4 H, J  6.5 Hz), 8.43 (s, 2 H), 8.23 (d, 4 H, J  6.7
Hz), 4.55 (t, 4 H, J  7.4 Hz), 1.93-1.85 (m, 4 H), 1.30-1.22 (m, 10 H);were obtained on Bruker AC-300, Bruker Avance 500, or Bruker
Avance 600 instruments. Chemical shifts are reported in  units 13C-NMR (75.46 MHz, DMSO-d6)  148.3, 145.1, 144.9, 124.0, 60.2,
30.5, 28.5, 28.2, 25.3. Anal. (C21H30Br2N4O2) C, H, N.using TMS (  0 ppm) as an internal standard for 1H-NMR spectra.
13C-NMR spectra are referenced to solvent peak when dissolved in
DMSO-d6 and referenced to CDCl3 (  77.0 ppm) as an external 1,6-Hexylene-bis-N,N’-3-Pyridiniumaldoxime Dibromide (2e)
standard when dissolved in D2O. Coupling constants are reported in Yield: 82% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.24
Hertz. All bis-oxime products decomposed (	175
C) before melting. (s, 2 H), 9.32 (s, 2 H), 9.15 (d, 2 H, J  5.7 Hz), 8.73 (d, 2 H, J  8.2
Hz), 8.36 (s, 2 H), 8.18 (dd, 2 H, J  8.0, 6.1 Hz), 4.64 (t, 4 H, J 
1,2-Ethylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1a) 7.5 Hz), 2.00-1.90 (m, 4 H), 1.40-1.33 (m, 4 H); 13C-NMR (75.46 MHz,
Pyridinium-2-carboxaldehyde oxime (1.00 g, 8.2 mmol), 1,2-ethylene DMSO-d6)  144.4, 143.2, 142.5, 141.2, 133.4, 128.0, 60.7, 30.1, 24.6.
dibromide (0.28 ml, 3.2 mmol), and absolute ethanol (10 ml) were Anal. (C18H24Br2N4O2) C, H, N.
added to a 23 ml Parr reaction vessel. The vessel was sealed, then
placed in a 130
C oven for 48 hr. After cooling to room temperature, 1,7-Heptylene-bis-N,N’-3-Pyridiniumaldoxime Dibromide (2f)
the Parr reaction vessel was opened and the reaction mixture was Yield: 82% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.25
filtered. The precipitate was added to water (100 ml) and extracted (s, 2 H), 9.33 (s, 2 H), 9.11 (d, 2 H, J  6.0 Hz), 8.74 (d, 2 H, J  8.2
with ethyl acetate (3 50 ml). The aqueous solution was lyophilized Hz), 8.36 (s, 2 H), 8.18 (dd, 2 H, J  8.0, 6.2 Hz), 4.64 (t, 4 H, J 
to give a crude product that was recrystallized from a mixture of 7.4 Hz), 1.99-1.89 (m, 4 H), 1.40-1.25 (m, 6 H); 13C-NMR (75.46 MHz,
water (20 ml) and isopropanol (50 ml). Yield: 63% as white powder; DMSO-d6)  144.4, 143.2, 142.5, 141.2, 133.4, 128.0, 60.8, 30.4, 27.6,1H-NMR (300 MHz, DMSO-d6)  12.87 (s, 2 H), 8.88 (d, 4 H, J  6.8 25.0. Anal. (C19H26Br2N4O2) C, H, N.
Hz), 8.45 (s, 2 H), 8.27 (d, 4 H, J  6.7 Hz), 5.21 (s, 4 H); 13C-NMR
(75.46 MHz, D2O)  153.1, 148.6, 147.4, 128.1, 62.2. Anal. 1,8-Octylene-bis-N,N’-3-Pyridiniumaldoxime Dibromide (2g)
(C14H16Br2N4O2·1.1H2O) C, H, N. Yield: 80% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.24
(s, 2 H), 9.31 (s, 2 H), 9.09 (d, 2 H, J  6.0 Hz), 8.73 (d, 2 H, J  8.1
The general procedure for synthesis of 1b–h and 2e–h was as
Hz), 8.36 (s, 2 H), 8.17 (dd, 2 H, J  8.1, 6.1 Hz), 4.63 (t, 4 H, J 
follows: 4-Pyridinealdoxime (2.8 g, 23.4 mmol) and 1,7-dibromohep-
7.5 Hz), 1.96-1.88 (m, 4 H), 1.34-1.25 (m, 8 H); 13C-NMR (75.46 MHz,
tane (2.0 g, 7.8 mmol) were added to 30 ml of absolute ethanol. The
DMSO-d6)  144.4, 143.2, 142.5, 141.3, 133.4, 128.0, 60.9, 30.5, 28.1,reaction mixture was heated at reflux for 48 hr and then cooled to
25.2. Anal. (C20H28Br2N4O2·0.5 H2O) C, H, N.room temperature. The product was collected by filtration, rinsed
with 2 ml of cold absolute ethanol, then dried under vacuum.
1,9-Nonylene-bis-N,N’-3-Pyridiniumaldoxime Dibromide (2h)
Yield: 70% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.241,3-Propylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1b)
(s, 2 H), 9.31 (s, 2 H), 9.08 (d, 2 H, J  6.1 Hz), 8.73 (d, 2 H, J  8.2Yield: 79% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.86
Hz), 8.35 (s, 2 H), 8.17 (dd, 2 H, J  8.1, 6.1 Hz), 4.63 (t, 4 H, J (s, 2H), 9.07 (d, 4 H, J  6.8 Hz), 8.46 (s, 2 H), 8.28 (d, 4 H, J  6.7
7.5 Hz), 1.96-1.88 (m, 4 H), 1.32-1.23 (m, 10 H); 13C-NMR (75.46 MHz,Hz), 4.71 (t, 4 H, J  7.3 Hz), 2.64 (p, 2 H, J  7.2 Hz); 13C-NMR
DMSO-d6)  144.4, 143.2, 142.5, 141.2, 133.4, 128.0, 60.9, 30.5, 28.4,(75.46 MHz, D2O)  151.6, 148.8, 147.3, 127.8, 60.4, 34.4. Anal.
28.2, 25.3. Anal. (C20H28Br2N4O2) C, H, N.(C15H18Br2N4O2·H2O) C, H, N.
The general procedure for synthesis of 3b–h was as follows:1,4-Butylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1c)
2-Pyridinealdoxime (8.06 g, 66.0 mmol, 2.2 eq.) was added to aYield: 93% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.84
solution of 1,7-heptanediol bistriflate (11.88 g, 30.0 mmol) in CH3CN(s, 2 H), 9.04 (d, 4 H, J  6.8 Hz), 8.44 (s, 2 H), 8.25 (d, 4 H, J  6.7
(90 ml) with stirring at room temperature. After stirring for 3 hr underHz), 4.63 (m, 4 H), 1.95 (m, 4 H); 13C-NMR (75.46 MHz, D2O)  151.3,
nitrogen, CH3CN was removed by using a rotavapor under low pres-148.7, 147.1, 127.6, 63.1, 29.9. Anal. (C16H20Br2N4O2) C, H, N.
sure. The resulting oily residue was dissolved in water (100 ml) and
slowly passed through a column of Dowex 1 8-200 chloride ion1,5-Pentylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1d)
exchange resin (100 g). The elute was concentrated by using aYield: 73% as white powder; 1H-NMR (300 MHz, DMSO-d6)  12.83 rotavapor under low pressure, further dried under high vacuum, and(s, 2 H), 9.10 (d, 4 H, J  6.6 Hz), 8.45 (s, 2 H), 8.25 (d, 4 H, J  6.7
the resulting crude product was triturated with EtOH/MTBE (30 ml/Hz), 4.60 (t, 4 H, J  7.3 Hz), 1.97 (m, 4 H), 1.32 (p, 2 H, J  6.8 Hz);
90 ml) to afford the desired product, 3f containing 7% of 2-pyridi-13C-NMR (75.46 MHz, D2O)  150.9, 148.7, 147.2, 127.5, 63.7, 32.6, nealdoxime. Further purification by recrystallization from MeOH/24.7. Anal. (C17H22Br2N4O2·0.3 H2O) C, H, N. MTBE (270 ml/270 ml) gave pure 3f (9.41 g, 76%) as a white solid.
1,6-Hexylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1e)
1,3-Propylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3b)Yield: 87% as white powder; 1H NMR (300 MHz, DMSO-d6)  12.83
Yield: 73% as white powder; 1H-NMR (300 MHz, DMSO-d6)  13.33(s, 2 H), 9.04 (d, 4 H, J  6.6 Hz), 8.44 (s, 2 H), 8.24 (d, 4 H, J  6.7
(s, 2 H), 9.18 (d, 2 H, J  5.4 Hz), 8.91 (s, 2 H), 8.56 (m, 2 H), 8.43Hz), 4.56 (t, 4 H, J  7.4 Hz), 1.94-1.87 (m, 4 H), 1.35-1.30 (m, 4 H);
(d, 2 H, J  7.7 Hz), 8.13 (m, 2 H), 4.90 (t, 4 H, J  7.5 Hz), 2.96 (m,13C NMR (75.46 MHz, DMSO-d6)  148.3, 145.1, 145.0, 124.0, 60.0,
2 H); 13C-NMR (75.46 MHz, D2O)  146.7, 146.4, 146.1, 142.4, 128.35,30.2, 24.6. Anal. (C18H24Br2N4O2) C, H, N.
128.31, 55.5, 30.8. Anal. (C15H18Cl2N4O2) C, H, N.
1,7-Heptylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1f)
1,4-Butylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3c)Yield: 85% as white needles; 1H-NMR (300 MHz, DMSO-d6)  12.83
Yield: 80% as white powder; 1H-NMR (300 MHz, DMSO-d6)  13.24(s, 2 H), 9.04 (d, 4 H, J  6.3 Hz), 8.44 (s, 2 H), 8.24 (d, 4 H, J  6.6
(s, 2 H), 8.98 (d, 2 H, J  5.7 Hz), 8.80 (s, 2 H), 8.55 (m, 2 H), 8.43Hz), 4.56 (t, 4 H, J  7.4 Hz), 1.93-1.85 (m, 4 H), 1.36-1.30 (m, 2 H),
(d, 2 H, J  8.1 Hz), 8.09 (m, 2 H), 4.76 (m, 4 H), 1.90 (m, 4 H);1.30-1.23 (m, 4 H); 13C-NMR (75.46 MHz, DMSO-d6)  148.3, 145.1,
13C-NMR (75.46 MHz, D2O)  149.1, 148.3, 148.2, 144.5, 130.5, 129.9,144.9, 124.0, 60.2, 30.4, 27.7, 25.1. Anal. (C19H26Br2N4O2) C, H, N.
60.4, 29.1. Anal. (C16H20Cl2N4O2·2H2O) C, H, N.
1,8-Octylene-bis-N,N’-4-Pyridiniumaldoxime Dibromide (1g)
Yield: 74% as white needles; 1H-NMR (300 MHz, DMSO-d6)  12.83 1,5-Pentylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3d)
Yield: 77% as white powder; 1H-NMR (300 MHz, DMSO-d6):  13.17(s, 2 H), 9.04 (d, 4 H, J  6.4 Hz), 8.43 (s, 2 H), 8.23 (d, 4 H, J  6.6
Hz), 4.55 (t, 4 H, J  7.3 Hz), 1.93-1.85 (m, 4 H), 1.32-1.23 (m, 8 H); (s, 2 H), 8.99 (d, 2 H, J  6.1 Hz), 8.77 (s, 2 H), 8.56 (m, 2 H), 8.42
(d, 2 H, J  8.1 Hz), 8.11 (m, 2 H), 4.70 (t, 4 H, J  7.4 Hz), 1.85 (m,13C-NMR (75.46 MHz, DMSO-d6)  148.3, 145.1, 144.9, 124.0, 60.1,
30.5, 28.1, 25.2. Anal. (C20H28Br2N4O2) C, H, N. 4 H), 1.40 (m, 2 H); 13C-NMR (75.46 MHz, D2O):  146.7, 145.7, 142.17,
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142.15, 128.1, 127.3, 58.6, 29.6, 22.3; Anal. (C17H22Cl2N4O2·2.5H2O) 1 by nonlinear regression with SigmaPlot 5.01 (Jandel Scientific).
This analysis neglects the competing dealkylation shown in SchemeC, H, N.
I of Figure 2 and thus results in about 30% loss of the reactivation
in the case of isoflurophate, which has appreciable dealkylation1,6-Hexylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3e)
under the test condition.Yield: 85% as white powder; 1H-NMR (300 MHz, DMSO-d6)  13.20
In order to estimate the dissociation constant of the oxime com-(s, 2 H), 9.05 (d, 2 H, J  6.0 Hz), 8.79 (s, 2 H), 8.57-8.52 (m, 2 H),
plex with unphosphorylated hAChE, we used the inhibitory proper-8.40 (d, 2 H, J  7.8 Hz), 8.12-8.07 (m, 2 H), 4.72 (t, 4 H, J  7.5
ties of our compounds to determine Ki values. For this purpose,Hz), 1.82-1.75 (m, 4 H), 1.38-1.34 (m, 4 H); 13C-NMR (75.46 MHz,
hAChE activity was measured at multiple substrate concentrationsDMSO-d6)  147.0, 146.0, 145.0, 141.2, 127.1, 125.7, 57.5, 29.9, 24.6;
in the presence of multiple concentrations of oxime. Maximal veloci-Anal. (C17H22Cl2N4O2·2.2H2O) C, H, N.
ties at each concentration of oxime were calculated by fitting data
to the standard Michaelis-Menten equation. Because double recip-1,7-Heptylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3f)
rocal plots of these data all intersected on or near the x axis, theYield: 76% as white powder; 1H-NMR (300 MHz, DMSO-d6)  13.23
inhibition was treated as noncompetitive. Accordingly, the inhibition(s, 2 H), 9.07 (d, 2 H, J  6.2 Hz), 8.78 (s, 2 H), 8.57-8.53 (m, 2 H),
constants were derived by fitting to Equation 2:8.40 (d, 2 H, J  8.0 Hz), 8.12-8.07 (m, 2 H), 4.73 (t, 4 H, J  7.6
Hz), 1.82-1.74 (m, 4 H), 1.36-1.26 (m, 6 H); 13C-NMR (75.46 MHz,
Vmax app  Vmax/(1  D/Ki). (2)DMSO-d6)  146.8, 146.0, 145.1, 141.2, 127.3, 125.9, 57.7, 30.2, 27.7,
25.0; Anal. (C19H26Cl2N4O2·2.6H2O) C, H, N. Here, Vmax app is apparent maximal velocity in the presence of oxime,
Vmax is the true maximal velocity, D is oxime concentration, and Ki
1,8-Octylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3g) is the inhibition constant.
Yield: 72% as white powder; 1H-NMR (300 MHz, DMSO-d6)  13.20
(s, 2 H), 9.05 (d, 2 H, J  6.2 Hz), 8.78 (d, 2 H, J  1.8 Hz), 8.56- DFT Calculations
8.51 (m, 2 H), 8.40 (d, 2 H, J  8.1 Hz), 8.11-8.06 (m, 2 H), 4.72 (t, 4 Four different conformations of 2-PAM were generated manually
H, J 7.6 Hz), 1.71-1.63 (m, 4 H), 1.34-1.23 (m, 8 H); 13C-NMR (75.46 with the QUANTA program [41]. The structures optimized with the
MHz, DMSO-d6)  146.8, 146.1, 145.2, 141.2, 127.3, 125.8, 57.7, 30.2, CHARMm force field [42] were subject to energy minimizations and
28.0, 25.1. Anal. (C20H28Cl2N4O2·0.7H2O) C, H, N. frequency calculations with the B3LYP/6-31G(d,p) method using
the Gaussian 98 program [43–45]. The structures optimized in vacuo
1,9-Nonylene-bis-N,N’-2-Pyridiniumaldoxime Dichloride (3h) were subjected to energy minimizations and frequency calculations
Yield: 75% as white powder; 1H-NMR (300 MHz, DMSO-d6)  13.19 using the B3LYP/6-31G(d,p) method in water (  78.39) with the
(s, 2 H), 9.03 (d, 2 H, J  6.9 Hz), 8.79 (s, 2 H), 8.56-8.53 (m, 2 H), Onsager solvent model [19–22]. No imaginary frequency was found
8.40 (d, 2 H, J  8.0 Hz), 8.12-8.06 (m, 2 H), 4.71 (t, 4 H, J  7.6 for any of the optimized structures reported in Figure 1.
Hz), 1.82-1.74 (m, 4 H), 1.34-1.21 (m, 10 H); 13C-NMR (75.46 MHz,
DMSO-d6)  146.8, 146.1, 145.1, 141.2, 127.3, 125.8, 57.7, 30.3, 28.4, Molecular Mechanics Calculations
28.2, 25.2. Anal. (C17H22Cl2N4O2·1.3H2O) C, H, N. The 3D structures of diisopropylphosphoryl-hAChE, 2-PAM, 4-PAM,
1b and 3f were generated by employing the PREP, LINK, EDIT,
Biological Testing PARM, and SANDER modules of the AMBER 5.0 program [46] with
A reactivation assay used freshly inhibited hAChE in membranes the force field by Cornell et al. (parm99.dat) [47] and additional
prepared from human red blood cells. A suspension of washed red force field parameters provided in the Supplemental Data. The RESP
cell membranes (500 l aliquots of a 50-fold dilution) were treated charges of these molecules were generated by calculating electro-
for 60 min at 23
C with organophosphate anticholinesterase static potentials using the GAUSSIAN 98 program [43] with the HF/
(echothiophate or, in particular experiments, isoflurophate), 107 M 6-31G*//HF/6-31G* method followed by a two-stage fitting using the
in 50 mM Tris HCl (pH 7.4). Subsequently, the hAChE inhibitor was RESP module of the AMBER 5.0 program [48]. The RESP charges
removed by two successive rinses involving centrifugation (8000  are available in the Supplemental Data. The diisopropylphosphoryl-
g, 10 min) and resuspension in the original volume of buffer. This hAChE structure was generated from the amino acid sequence of
treatment regularly led to a stable 99% inhibition of hAChE (control hAChE (Entrez Protein Database 1B41A; http://www.ncbi.nlm.nih.
experiments with the reversible anticholinesterase, BW284C51, gov) and the coordinates of corresponding residues in the X-ray
showed that the rinsing was adequate to remove free inhibitor). structure of hAChE (PDB ID code 1B41) [49]. Modifications included
Spontaneous reactivation was negligible over periods of up to 2 hr (1) replacement of Ser200 with a diisopropylphosphorylated serine
in the absence of reactivator (2%). Reactivating agents were residue (the residue file is available in the Supplemental Data); (2)
added at a range of concentrations for up to 1 hr at 37
C. Following protonation or deprotonation of the Arg, Lys, Asp, Glu, His, and Cys
the reactivation step, red cell membranes were rinsed again (see residues; (3) conformational search of the diisopropylphosphoryl
above), and 10 l aliquots were transferred to a microtiter plate for group in the active site of hAChE (vide infra); (4) adjustment of the
assay by a standard spectrophotometric method [40]. Reagents acyl pocket loop conformation according to the conformation found
were added to wells of a microtiter plate in this order: hAChE extract, in the X-ray structure of an aged phosphylated hAChE (PDB ID code
reaction buffer, substrate-free reaction cocktail, and bis-oxime. 2DFP) [32]; (5) energy minimization of the resulting structure; and
After a 5 min preincubation, acetylthiocholine iodide substrate was (6) refinement of the energy-minimized structure by 20 independent
added at final concentrations from 0.033 mM to 1 mM, and the 1.0 ns (1.0 fs time step) MD simulations with different initial velocities
reactions were monitored in a plate reader. (vide infra). The protonation states of the Arg, Lys, Asp, Glu, His,
Analysis of enzyme reactivation assumed that the tested oximes and Cys residues were determined according to the published pro-
bound rapidly and reversibly to phosphorylated enzyme, slowly ac- tocol [50]. His440 residue that constitutes the catalytic triad was
cepted the phosphate residue, then rapidly dissociated, according treated as protonated because Ser200 was diisopropylphosphory-
to Scheme I of Figure 2. For analytical simplicity, the second reaction lated.
was treated as irreversible, since back reaction is negligible at the
low expected concentrations of phosphorylated oxime. Thus, the reac- Conformational Analyses
tivation of phosphorylated hAChE was described by Equation 1: Conformational searches were performed for the diisopropylphos-
phoryl group, 1b and 3f, employing the CONSER program (devised
R  E(1  e
k3(
D
DKD
)t
). (1) by Y.-P. Pang). This program first generated conformations by speci-
fying all discrete possibilities at 120˚ of arc increments in a range of
0 to 360 for all rotatable bonds of the diisopropylphosphoryl group,Here, R is recovered enzyme activity, E is total activity before inhibi-
tion, t is time in minutes, k3 is the rate constant for reactivation, D 1b and 3f. It then optimized such conformers with the RESP charges
and the Cornell et al. force field (parm99.dat) [47]. Afterwards, itis oxime concentration, and KD is the dissociation constant of the
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